Amedeo Smart

Free Medical Literature Service


 

Amedeo

Hypertension

  Free Subscription

Articles published in
J Am Soc Hypertens
    April 2018
  1. FAN YL, Zhan R, Dong YF, Huang L, et al
    Significant interaction of hypertension and homocysteine on neurological severity in first-ever ischemic stroke patients.
    J Am Soc Hypertens. 2018 Apr 3. pii: S1933-1711(18)30088.
    >> Share

    March 2018
  2. TIAN Z, Li Y, Li L, Liu X, et al
    Dose-response relationship between visceral fat index and untreated hypertension in Chinese rural population: the RuralDiab study.
    J Am Soc Hypertens. 2018 Mar 29. pii: S1933-1711(18)30077.
    >> Share

  3. JEDRUSIK P, Symonides B, Gaciong Z
    Comparison of three formulas to estimate 24-hour urinary sodium and potassium excretion in patients hospitalized in a hypertension unit.
    J Am Soc Hypertens. 2018 Mar 28. pii: S1933-1711(18)30078.
    >> Share

  4. YANG B, Wang Y, Zhang F, Ju W, et al
    Rationale and evidence for the development of a durable device-based cardiac neuromodulation therapy for hypertension.
    J Am Soc Hypertens. 2018 Mar 21. pii: S1933-1711(18)30072.
    >> Share

  5. TOUYZ RM, Herrmann SMS, Herrmann J
    Vascular toxicities with VEGF inhibitor therapies-focus on hypertension and arterial thrombotic events.
    J Am Soc Hypertens. 2018 Mar 21. pii: S1933-1711(18)30076.
    >> Share

  6. LIU Z, Liu J, Xiao M, Wang J, et al
    Mesenchymal stem cell-derived microvesicles alleviate pulmonary arterial hypertension by regulating renin-angiotensin system.
    J Am Soc Hypertens. 2018 Mar 15. pii: S1933-1711(18)30045.
    >> Share

  7. OLIVER-WILLIAMS C, Howard AG, Navas-Acien A, Howard BV, et al
    Cadmium body burden, hypertension, and changes in blood pressure over time: results from a prospective cohort study in American Indians.
    J Am Soc Hypertens. 2018 Mar 10. pii: S1933-1711(18)30053.
    >> Share

  8. JIANG M, Zha X, Wu Z, Zhu X, et al
    Inverted U-shaped curve relationship between red blood cell distribution width and hypertension in a large health checkup population in China.
    J Am Soc Hypertens. 2018 Mar 10. pii: S1933-1711(18)30054.
    >> Share

  9. HUANG H, Wang W, Yang G, Zhang Y, et al
    Circulating bone morphogenetic protein-9 levels are associated with hypertension and insulin resistance in humans.
    J Am Soc Hypertens. 2018 Mar 1. pii: S1933-1711(18)30046.
    >> Share

  10. USHIGOME E, Oyabu C, Tanaka T, Hasegawa G, et al
    Impact of masked hypertension on diabetic nephropathy in patients with type II diabetes: a KAMOGAWA-HBP study.
    J Am Soc Hypertens. 2018 Mar 1. pii: S1933-1711(18)30044.
    >> Share

    February 2018
  11. GEORGIANOS PI, Champidou E, Liakopoulos V, Balaskas EV, et al
    Home blood pressure-guided antihypertensive therapy in chronic kidney disease: more data are needed.
    J Am Soc Hypertens. 2018 Feb 10. pii: S1933-1711(18)30018.
    >> Share

  12. SHEN Y, Wang X, Wang Z, Zhang L, et al
    Prevalence, awareness, treatment, and control of hypertension among Chinese working population: results of a workplace-based study.
    J Am Soc Hypertens. 2018 Feb 10. pii: S1933-1711(18)30017.
    >> Share

  13. SHITTU RO, Odeigah LO, Fakorede KO, Sikiru BA, et al
    Prevalence and correlates of hypertension-outcome of a free medical screening in Oke-Ogun area of Oyo state, Nigeria, West Africa.
    J Am Soc Hypertens. 2018 Feb 1. pii: S1933-1711(18)30010.
    >> Share

    January 2018
  14. DER MESROPIAN PJ, Shaikh G, Cordero Torres E, Bilal A, et al
    Antihypertensive therapy in nondiabetic chronic kidney disease: a review and update.
    J Am Soc Hypertens. 2018 Jan 30. pii: S1933-1711(18)30006.
    >> Share

  15. DI STEFANO C, Vanni E, Mirabella S, Younes R, et al
    Risk factors for arterial hypertension after liver transplantation.
    J Am Soc Hypertens. 2018 Jan 5. pii: S1933-1711(18)30003.
    >> Share

  16. REGNAULT V, Lacolley P, Safar ME
    Hypertension in postmenopausal women: hemodynamic and therapeutic implications.
    J Am Soc Hypertens. 2018 Jan 4. pii: S1933-1711(18)30002.
    >> Share

  17. YU S, Xiong J, Lu Y, Chi C, et al
    The prevalence of central hypertension defined by a central blood pressure type I device and its association with target organ damage in the community-dwelling elderly Chinese: The Northern Shanghai Study.
    J Am Soc Hypertens. 2018 Jan 3. pii: S1933-1711(18)30001.
    >> Share

  18. CHRISTOFARO DGD, Mesas AE, Ritti Dias RM, Fernandes RA, et al
    Association between hypertension in adolescents and the health risk factors of their parents: an epidemiological family study.
    J Am Soc Hypertens. 2018 Jan 2. pii: S1933-1711(17)30440.
    >> Share

    December 2017
  19. ZHU H, Zhu L, Fang Z, Yang S, et al
    Common variants at somatostatin are significantly associated with hypertension incidence in smoking and drinking populations.
    J Am Soc Hypertens. 2017 Dec 28. pii: S1933-1711(17)30438.
    >> Share

  20. KIEU A, Shaikh A, Kaeppler M, Miles RJ, et al
    Patients with hypertensive responses to exercise or dobutamine stress testing differ in resting hypertensive phenotype.
    J Am Soc Hypertens. 2017 Dec 14. pii: S1933-1711(17)30417.
    >> Share

  21. GKALIAGKOUSI E, Anyfanti P, Triantafyllou A, Gavriilaki E, et al
    Aldosterone as a mediator of microvascular and macrovascular damage in a population of normotensive to early-stage hypertensive individuals.
    J Am Soc Hypertens. 2017 Dec 11. pii: S1933-1711(17)30414.
    >> Share

  22. ERDEM Y, Ozkan G, Ulusoy S, Arici M, et al
    The effect of intermittent fasting on blood pressure variability in patients with newly diagnosed hypertension or prehypertension.
    J Am Soc Hypertens. 2017 Dec 6. pii: S1933-1711(17)30412.
    >> Share

    November 2017
  23. TEYMOORI F, Asghari G, Mirmiran P, Azizi F, et al
    High dietary intake of aromatic amino acids increases risk of hypertension.
    J Am Soc Hypertens. 2017 Nov 24. pii: S1933-1711(17)30407.
    >> Share

  24. RAM CVS
    Latest guidelines for hypertension: adopt and adapt.
    J Am Soc Hypertens. 2017 Nov 13. pii: S1933-1711(17)30405.
    >> Share

  25. WANG D, Zhou M, Li W, Kong W, et al
    Occupational noise exposure and hypertension: the Dongfeng-Tongji Cohort Study.
    J Am Soc Hypertens. 2017 Nov 13. pii: S1933-1711(17)30383.
    >> Share

    October 2017
  26. KLIMCZAK D, Kuch M, Pilecki T, Zochowska D, et al
    Plasma microRNA-155-5p is increased among patients with chronic kidney disease and nocturnal hypertension.
    J Am Soc Hypertens. 2017 Oct 28. pii: S1933-1711(17)30378.
    >> Share

  27. LI G, Zhang H, Zhao L, Zhang Y, et al
    Angiotensin-converting enzyme 2 activation ameliorates pulmonary endothelial dysfunction in rats with pulmonary arterial hypertension through mediating phosphorylation of endothelial nitric oxide synthase.
    J Am Soc Hypertens. 2017 Oct 28. pii: S1933-1711(17)30379.
    >> Share

  28. XIAO Y, Long WQ, Guan KP, Long M, et al
    Role of angiotensin II type 2 receptor during electrophysiological remodeling of left ventricular hypertrophic myocardium in spontaneously hypertensive rats.
    J Am Soc Hypertens. 2017 Oct 13. pii: S1933-1711(17)30343.
    >> Share

  29. FENG L, Khan AH, Jehan I, Allen J, et al
    Albuminuria and kidney function as prognostic marker of left ventricular mass among South Asians with hypertension.
    J Am Soc Hypertens. 2017 Oct 13. pii: S1933-1711(17)30341.
    >> Share

  30. BISOGNANO JD, Basile JN
    From the President, American Society of Hypertension.
    J Am Soc Hypertens. 2017 Oct 12. pii: S1933-1711(17)30364.
    >> Share

  31. KOVESDY CP, Appel LJ, Grams ME, Gutekunst L, et al
    Potassium homeostasis in health and disease: A scientific workshop cosponsored by the National Kidney Foundation and the American Society of Hypertension.
    J Am Soc Hypertens. 2017 Oct 6. pii: S1933-1711(17)30337.
    >> Share

    September 2017
  32. WANG YT, Adi D, Yu ZX, Ma YT, et al
    The burden and correlates of hypertension among Chinese rural population in Han, Uygur, and Kazak: a cross-sectional study.
    J Am Soc Hypertens. 2017 Sep 28. pii: S1933-1711(17)30336.
    >> Share

  33. PLOTNIKOV MB, Shamanaev AY, Aliev OI, Sidekhmenova AV, et al
    Pentoxifylline treatment enhances antihypertensive activity of captopril through hemorheological improvement in spontaneously hypertensive rats during development of arterial hypertension.
    J Am Soc Hypertens. 2017 Sep 27. pii: S1933-1711(17)30333.
    >> Share

  34. SANIDAS E, Papadopoulos DP, Grassos H, Velliou M, et al
    Air pollution and arterial hypertension. A new risk factor is in the air.
    J Am Soc Hypertens. 2017 Sep 27. pii: S1933-1711(17)30334.
    >> Share

  35. KOVO M, Bar J, Schreiber L, Shargorodsky M, et al
    The relationship between hypertensive disorders in pregnancy and placental maternal and fetal vascular circulation.
    J Am Soc Hypertens. 2017 Sep 6. pii: S1933-1711(17)30305.
    >> Share

  36. BUTLER MJ, Tanner RM, Muntner P, Shimbo D, et al
    Adherence to antihypertensive medications and associations with blood pressure among African Americans with hypertension in the Jackson Heart Study.
    J Am Soc Hypertens. 2017;11:581-588.
    >> Share

    August 2017
  37. MARKETOU ME, Kontaraki JE, Papadakis JA, Vrentzos GE, et al
    Increased platelet alpha2B-adrenergic receptor gene expression in well-controlled hypertensives: the effect of arterial stiffness.
    J Am Soc Hypertens. 2017 Aug 26. pii: S1933-1711(17)30298.
    >> Share

  38. HODSON B, Norton GR, Ballim I, Sareli P, et al
    Contribution of backward and forward wave pressures to age-related increases in aortic pressure in a community sample not receiving antihypertensive therapy.
    J Am Soc Hypertens. 2017 Aug 24. pii: S1933-1711(17)30295.
    >> Share

    July 2017
  39. LUO H, Liu B, Zhao L, He J, et al
    Galectin-3 mediates pulmonary vascular remodeling in hypoxia-induced pulmonary arterial hypertension.
    J Am Soc Hypertens. 2017 Jul 28. pii: S1933-1711(17)30264.
    >> Share

  40. SIMPLICIO JA, Gonzaga NA, Nakashima MA, De Martinis BS, et al
    Tumor necrosis factor-alpha receptor 1 contributes to ethanol-induced vascular reactive oxygen species generation and hypertension.
    J Am Soc Hypertens. 2017 Jul 22. pii: S1933-1711(17)30263.
    >> Share

  41. XIAO S, Zhang M, Liang Y, Wang D, et al
    Celastrol synergizes with oral nifedipine to attenuate hypertension in preeclampsia: a randomized, placebo-controlled, and double blinded trial.
    J Am Soc Hypertens. 2017 Jul 20. pii: S1933-1711(17)30259.
    >> Share

  42. KRONISH IM, Kent S, Moise N, Shimbo D, et al
    Barriers to conducting ambulatory and home blood pressure monitoring during hypertension screening in the United States.
    J Am Soc Hypertens. 2017 Jul 6. pii: S1933-1711(17)30254.
    >> Share

  43. ZHANG Y, Sun N, Jiang X, Xi Y, et al
    Comparative efficacy of beta-blockers on mortality and cardiovascular outcomes in patients with hypertension: a systematic review and network meta-analysis.
    J Am Soc Hypertens. 2017;11:394-401.
    >> Share

    June 2017
  44. WANG XX, Shuai W, Peng Q, Li JX, et al
    White coat effect in hypertensive patients: the role of hospital environment or physician presence.
    J Am Soc Hypertens. 2017 Jun 21. pii: S1933-1711(17)30192.
    >> Share

  45. XU Y, Chen X, Wang K
    Global prevalence of hypertension among people living with HIV: a systematic review and meta-analysis.
    J Am Soc Hypertens. 2017 Jun 21. pii: S1933-1711(17)30190.
    >> Share

  46. ENGELI S, May M, Nussberger J, Danser AHJ, et al
    Systemic and tissue-specific effects of aliskiren on the RAAS and carbohydrate/lipid metabolism in obese patients with hypertension.
    J Am Soc Hypertens. 2017 Jun 12. pii: S1933-1711(17)30188.
    >> Share

  47. EYUBOGLU M, Karabag Y, Karakoyun S, Akdeniz B, et al
    The effect of circadian blood pressure pattern on presence of fragmented QRS complexes in hypertensive subjects.
    J Am Soc Hypertens. 2017 Jun 12. pii: S1933-1711(17)30187.
    >> Share

  48. HUANG G, Xu JB, Zhang TJ, Li Q, et al
    Prevalence, awareness, treatment, and control of hypertension among very elderly Chinese: results of a community-based study.
    J Am Soc Hypertens. 2017 Jun 8. pii: S1933-1711(17)30186.
    >> Share

  49. BLOCH MJ
    The Dietary Approaches to Stop Hypertension (DASH) diet-Promise Unmet.
    J Am Soc Hypertens. 2017;11:323-324.
    >> Share

  50. GUPTA P, Hagberg R, Kaloudis E, Lucas A, et al
    Severe and resistant hypertension in an older woman with claudication.
    J Am Soc Hypertens. 2017 Jun 1. pii: S1933-1711(17)30174.
    >> Share

    May 2017
  51. WANG JG, Zhou D, Jeffers BW
    Predictors of visit-to-visit blood pressure variability in patients with hypertension: an analysis of trials with an amlodipine treatment arm.
    J Am Soc Hypertens. 2017 May 29. pii: S1933-1711(17)30154.
    >> Share

  52. FABIANI I, Pugliese NR, La Carrubba S, Conte L, et al
    Incremental prognostic value of a complex left ventricular remodeling classification in asymptomatic for heart failure hypertensive patients.
    J Am Soc Hypertens. 2017 May 25. pii: S1933-1711(17)30153.
    >> Share

  53. CHRYSANT SG
    Pharmacokinetic, pharmacodynamic, and antihypertensive effects of the neprilysin inhibitor LCZ-696: sacubitril/valsartan.
    J Am Soc Hypertens. 2017 May 25. pii: S1933-1711(17)30147.
    >> Share

  54. LIU X, Wang Y, Gao R, Xing Y, et al
    Serum metabolomic response to exercise training in spontaneously hypertensive rats.
    J Am Soc Hypertens. 2017 May 20. pii: S1933-1711(17)30151.
    >> Share

  55. PILLERON S, Aboyans V, Mbelesso P, Ndamba-Bandzouzi B, et al
    Prevalence, awareness, treatment, and control of hypertension in older people in Central Africa: the EPIDEMCA study.
    J Am Soc Hypertens. 2017 May 9. pii: S1933-1711(17)30148.
    >> Share

  56. UZIEBLO-ZYCZKOWSKA B, Krzesinski P, Gielerak G, Skrobowski A, et al
    Speckle tracking echocardiography and tissue Doppler imaging reveal beneficial effect of pharmacotherapy in hypertensives with asymptomatic left ventricular dysfunction.
    J Am Soc Hypertens. 2017 May 8. pii: S1933-1711(17)30099.
    >> Share

    April 2017
  57. GARFINKLE MA
    Salt and essential hypertension: pathophysiology and implications for treatment.
    J Am Soc Hypertens. 2017 Apr 14. pii: S1933-1711(17)30105.
    >> Share

  58. DEL MAURO JS, Prince PD, Donato M, Fernandez Machulsky N, et al
    Effects of carvedilol or amlodipine on target organ damage in L-NAME hypertensive rats: their relationship with blood pressure variability.
    J Am Soc Hypertens. 2017;11:227-240.
    >> Share

  59. DEGLI ESPOSTI D, Finzi SS, Parini A, Cicero AFG, et al
    Echocardiographic characteristics of hypertensive patients affected by transient ischemic attack: a cross-sectional study.
    J Am Soc Hypertens. 2017;11:213-219.
    >> Share

    March 2017
  60. GOLDBERG EM, Wilson T, Saucier C, Brody AM, et al
    Achieving the BpTRUth: emergency department hypertension screening and the Centers for Medicare & Medicaid Services quality measure.
    J Am Soc Hypertens. 2017 Mar 30. pii: S1933-1711(17)30093.
    >> Share

  61. MARTYNOWICZ H, Skomro R, Gac P, Mazur G, et al
    The influence of hypertension on daytime sleepiness in obstructive sleep apnea.
    J Am Soc Hypertens. 2017 Mar 27. pii: S1933-1711(17)30094.
    >> Share

  62. HE J, Li X, Luo H, Li T, et al
    Galectin-3 mediates the pulmonary arterial hypertension-induced right ventricular remodeling through interacting with NADPH oxidase 4.
    J Am Soc Hypertens. 2017 Mar 27. pii: S1933-1711(17)30098.
    >> Share

  63. HAN W, Fang W, Gan Q, Guan S, et al
    Low-dose sustained-release deoxycorticosterone acetate-induced hypertension in Bama miniature pigs for renal sympathetic nerve denervation.
    J Am Soc Hypertens. 2017 Mar 2. pii: S1933-1711(17)30043.
    >> Share

  64. SPRADLING-REEVES KD, Shade RE, Haywood JR, Cox LA, et al
    Primate response to angiotensin infusion and high sodium intake differ by sodium lithium countertransport phenotype.
    J Am Soc Hypertens. 2017;11:178-184.
    >> Share

  65. ANDREADIS EA, Papademetriou V, Geladari CV, Kolyvas GN, et al
    Home, automated office, and conventional office blood pressure as predictors of cardiovascular risk.
    J Am Soc Hypertens. 2017;11:165-170.
    >> Share

  66. USHIGOME E, Matsumoto S, Oyabu C, Ushigome H, et al
    Olmesartan with azelnidipine versus with trichlormethiazide on home blood pressure variability in patients with type II diabetes mellitus.
    J Am Soc Hypertens. 2017;11:140-147.
    >> Share

    February 2017
  67. JURIO-IRIARTE B, Gorostegi-Anduaga I, Aispuru GR, Perez-Asenjo J, et al
    Association between Modified Shuttle Walk Test and cardiorespiratory fitness in overweight/obese adults with primary hypertension: EXERDIET-HTA study.
    J Am Soc Hypertens. 2017 Feb 7. pii: S1933-1711(17)30029.
    >> Share

  68. FANG M, Huang Y, Zhang Y, Ning Z, et al
    Interleukin-6 -572C/G polymorphism is associated with serum interleukin-6 levels and risk of idiopathic pulmonary arterial hypertension.
    J Am Soc Hypertens. 2017 Feb 3. pii: S1933-1711(17)30036.
    >> Share

  69. KUANG ZM, Wang Y, Wang JJ, Liu JH, et al
    The importance of genetic counseling and genetic screening: a case report of a 16-year-old boy with resistant hypertension and severe hypokalemia.
    J Am Soc Hypertens. 2017 Feb 3. pii: S1933-1711(17)30037.
    >> Share

  70. WACHTER R, Halbach M, Bakris GL, Bisognano JD, et al
    An exploratory propensity score matched comparison of second-generation and first-generation baroreflex activation therapy systems.
    J Am Soc Hypertens. 2017;11:81-91.
    >> Share

  71. GHAZI L, Dudenbostel T, Xing D, Ejem D, et al
    Assessment of vascular function in low socioeconomic status preschool children: a pilot study.
    J Am Soc Hypertens. 2017;11:101-109.
    >> Share

    January 2017
  72. FARAG EM, Al-Daydamony MM, Gad MM
    What is the association between left ventricular diastolic dysfunction and 6-minute walk test in hypertensive patients?
    J Am Soc Hypertens. 2017 Jan 28. pii: S1933-1711(17)30004.
    >> Share

  73. NGUYEN-HUYNH MN, Hills NK, Sidney S, Klingman JG, et al
    Race-ethnicity on blood pressure control after ischemic stroke: a prospective cohort study.
    J Am Soc Hypertens. 2017;11:38-44.
    >> Share

  74. ISLAM GM
    The risk of developing cardiovascular disease in Bangladesh: does diabetes mellitus matter? Which socioeconomic status does it impact? A cross sectional study.
    J Am Soc Hypertens. 2017;11:45-53.
    >> Share

    December 2016
  75. THOMAS SJ, Calhoun D
    Sleep, insomnia, and hypertension: current findings and future directions.
    J Am Soc Hypertens. 2016 Dec 29. pii: S1933-1711(16)30593.
    >> Share

  76. WU J, Jia J, Liu L, Yang F, et al
    Schisandrin B displays a protective role against primary pulmonary hypertension by targeting transforming growth factor beta1.
    J Am Soc Hypertens. 2016 Dec 28. pii: S1933-1711(16)30606.
    >> Share

  77. LESKOV I, Neville A, Shen X, Pardue S, et al
    Nicotinamide nucleotide transhydrogenase activity impacts mitochondrial redox balance and the development of hypertension in mice.
    J Am Soc Hypertens. 2016 Dec 16. pii: S1933-1711(16)30601.
    >> Share

  78. MAJERCZYK M, Choreza P, Bozentowicz-Wikarek M, Brzozowska A, et al
    Increased plasma RBP4 concentration in older hypertensives is related to the decreased kidney function and the number of antihypertensive drugs-results from the PolSenior substudy.
    J Am Soc Hypertens. 2016 Dec 7. pii: S1933-1711(16)30594.
    >> Share

  79. MANN SJ
    Redefining beta-blocker use in hypertension: selecting the right beta-blocker and the right patient.
    J Am Soc Hypertens. 2016 Dec 5. pii: S1933-1711(16)30591.
    >> Share

  80. VONDRACEK S, Scoular S, Patel T
    Management of severe asymptomatic hypertension in the hospitalized patient.
    J Am Soc Hypertens. 2016;10:974-984.
    >> Share

  81. ERNST ME, Davis BR, Soliman EZ, Prineas RJ, et al
    Electrocardiographic measures of left ventricular hypertrophy in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    J Am Soc Hypertens. 2016;10:930-938.
    >> Share

    November 2016
  82. SINGH RB, Hristova K, Bjorklund G, Fedacko J, et al
    Extended consensus on blood pressure variability beyond blood pressure for management of hypertension.
    J Am Soc Hypertens. 2016 Nov 25. pii: S1933-1711(16)30589.
    >> Share

  83. WILHELM M, Winkler A, Rief W, Doering BK, et al
    Effect of placebo groups on blood pressure in hypertension: a meta-analysis of beta-blocker trials.
    J Am Soc Hypertens. 2016 Nov 5. pii: S1933-1711(16)30559.
    >> Share

  84. DE LA SIERRA A, Banegas JR, Divison JA, Gorostidi M, et al
    Ambulatory blood pressure in hypertensive patients with inclusion criteria for the SPRINT trial.
    J Am Soc Hypertens. 2016 Nov 5. pii: S1933-1711(16)30563.
    >> Share

  85. RYOO JH, Park SK, Oh CM, Choi YJ, et al
    Evaluating the risk of hypertension according to the metabolic health status stratified by degree of obesity.
    J Am Soc Hypertens. 2016 Nov 2. pii: S1933-1711(16)30550.
    >> Share

  86. NIELSEN LH, Ovesen P, Hansen MR, Brantlov S, et al
    Changes in the renin-angiotensin-aldosterone system in response to dietary salt intake in normal and hypertensive pregnancy. A randomized trial.
    J Am Soc Hypertens. 2016;10:881-890.
    >> Share

  87. AFSAR B, Vaziri ND, Aslan G, Tarim K, et al
    Gut hormones and gut microbiota: implications for kidney function and hypertension.
    J Am Soc Hypertens. 2016 Nov 1. pii: S1933-1711(16)30551.
    >> Share

    October 2016
  88. LEVY PD, Willock RJ, Burla M, Brody A, et al
    Total antihypertensive therapeutic intensity score and its relationship to blood pressure reduction.
    J Am Soc Hypertens. 2016 Oct 28. pii: S1933-1711(16)30549.
    >> Share

  89. CASANOVA MA, Medeiros F, Trindade M, Cohen C, et al
    Omega-3 fatty acids supplementation improves endothelial function and arterial stiffness in hypertensive patients with hypertriglyceridemia and high cardiovascular risk.
    J Am Soc Hypertens. 2016 Oct 26. pii: S1933-1711(16)30548.
    >> Share

  90. PREGOWSKA-CHWALA B, Prejbisz A, Kabat M, Pucilowska B, et al
    Morning blood pressure surge and markers of cardiovascular alterations in untreated middle-aged hypertensive subjects.
    J Am Soc Hypertens. 2016;10:790-798.
    >> Share

    September 2016
  91. BLOCH MJ
    Worldwide prevalence of hypertension exceeds 1.3 billion.
    J Am Soc Hypertens. 2016 Sep 19. pii: S1933-1711(16)30489.
    >> Share

  92. HOLMQVIST L, Bostrom KB, Kahan T, Schioler L, et al
    Prevalence of treatment-resistant hypertension and important associated factors-results from the Swedish Primary Care Cardiovascular Database.
    J Am Soc Hypertens. 2016 Sep 6. pii: S1933-1711(16)30491.
    >> Share

    August 2016
  93. SCHWARTZ AB
    Complexity, controversies, and disagreements in hypertension treatment goals.
    J Am Soc Hypertens. 2016 Aug 4. pii: S1933-1711(16)30445.
    >> Share

  94. RABKIN SW
    Target blood pressure for patients with hypertension: lower blood pressure is not better.
    J Am Soc Hypertens. 2016;10:623-4.
    >> Share

    July 2016
  95. SERAFICA R, Angosta AD
    Acculturation and changes in body mass index, waist circumference, and waist-hip ratio among Filipino Americans with hypertension.
    J Am Soc Hypertens. 2016 Jul 26. pii: S1933-1711(16)30443.
    >> Share

  96. RAMTAHAL R, Dhanoo A
    Subclinical hypothyroidism causing hypertension in pregnancy.
    J Am Soc Hypertens. 2016 Jul 18. pii: S1933-1711(16)30406.
    >> Share

  97. PURAKAL J, Hughes-Strange G, Heinert S, Prendergast H, et al
    Elevated Blood Pressure in the Emergency Department: How Well Do Emergency Physicians Treat, Inform and Refer Their Hypertensive Patients Based on Chief Complaint?
    J Am Soc Hypertens. 2016;10 Suppl 1:e9.
    >> Share

  98. WEBER MA, Bakris GL, White WB, Xie L, et al
    The Effects of Nebivolol-Valsartan Single-Pill Combinations in Reducing Blood Pressure in Patients with Stage I or II Hypertension.
    J Am Soc Hypertens. 2016;10 Suppl 1:e8.
    >> Share

  99. RUILOPE LM, Nowack C, Bakris GL
    Masked and Nocturnal Hypertension in the ARTS-DN ABPM Sub-Study with Finerenone.
    J Am Soc Hypertens. 2016;10 Suppl 1:e7.
    >> Share

  100. ISHAK J, Rael M, Punzi H, Gradman A, et al
    Additivity of Nebivolol/Valsartan Single-Pill Combination Versus Other Single-Pill Combinations for Hypertension.
    J Am Soc Hypertens. 2016;10 Suppl 1:e5-e6.
    >> Share

  101. CAGNONI F, Sganzerla P, Bontempelli E, Masserini AB, et al
    RDN in Hypertensives: Results from a Novel Anatomical Approach.
    J Am Soc Hypertens. 2016;10 Suppl 1:e5.
    >> Share

  102. HUANG H, Han Y, Jose PA, Zeng C, et al
    Loss of Adiponectin-Induced Renal Sodium Excretion in Hypertension.
    J Am Soc Hypertens. 2016;10 Suppl 1:e4.
    >> Share

  103. FU J, Han Y, Wang J, Jose PA, et al
    Irisin Lowered Blood Pressure by Augmenting Acetylcholine-Mediated Vasodilation via AMPK-Akt-eNOS-NO Signal Pathway in the Spontaneously Hypertensive Rat.
    J Am Soc Hypertens. 2016;10 Suppl 1:e4.
    >> Share

  104. CHEN K, Fu C, Chen C, Jose PA, et al
    Role of GRK4 in the Regulation of Arterial AT1 Receptor in Hypertension.
    J Am Soc Hypertens. 2016;10 Suppl 1:e3.
    >> Share

  105. ZOU X, Wang J, Chen C, Jose PA, et al
    Secreted Monocyte miR-27a Causes Hypertension by Reducing Mas Receptor Expression and Function in the Artery.
    J Am Soc Hypertens. 2016;10 Suppl 1:e3.
    >> Share

  106. CABRERA-SOLE RM, Rivera LU, Lucas CT, Salazar DC, et al
    Isolate Systolic Hypertension and Central Pressures in Elderly Patients. Differences Between Men and Women with Similar Peripheral Pressures.
    J Am Soc Hypertens. 2016;10 Suppl 1:e2-e3.
    >> Share

  107. JADHAV UM, Kulkarni A
    Evaluation of Telmesartan Monotherapy on Morning Blood Pressure Surge in Patients with Mild to Moderate Hypertension.
    J Am Soc Hypertens. 2016;10 Suppl 1:e2.
    >> Share

  108. ARIAS T, Mateo J, Espana S, Izquierdo JL, et al
    Non-Invasive Imaging of Lung Remodeling and Right Ventricle Metabolic Shift in an Animal Model of Pulmonary Hypertension.
    J Am Soc Hypertens. 2016;10 Suppl 1:e1-e2.
    >> Share

  109. WANG Y, Zheng Y
    Inhibition of Big-Conductance Ca2+-Activated K+ Channels in Vascular Myocytes Is a Key Novel Mechanism for Immunodepressant-Induced Hypertension.
    J Am Soc Hypertens. 2016;10 Suppl 1:e1.
    >> Share

  110. CATENA C, Colussi G, Novello M, Brosolo G, et al
    Effects of Alcohol Consumption on Left Ventricular Diastolic Function in Hypertensive Patients.
    J Am Soc Hypertens. 2016;10 Suppl 1:e1.
    >> Share

    June 2016
  111. TOBE SW, Izzo JL Jr
    Controversies in hypertension: is lower blood pressure always better?
    J Am Soc Hypertens. 2016 Jun 29. pii: S1933-1711(16)30379.
    >> Share

  112. TADIC M, Cuspidi C, Vukomanovic V, Celic V, et al
    Does masked hypertension impact left ventricular deformation?
    J Am Soc Hypertens. 2016 Jun 27. pii: S1933-1711(16)30385.
    >> Share

  113. BHATT H, Gamboa CM, Safford MM, Soliman EZ, et al
    Prevalence of electrocardiographic abnormalities based on hypertension severity and blood pressure levels: the Reasons for Geographic and Racial Differences in Stroke study.
    J Am Soc Hypertens. 2016 Jun 27. pii: S1933-1711(16)30386.
    >> Share

  114. DIVISON-GARROTE JA, Banegas JR, De la Cruz JJ, Escobar-Cervantes C, et al
    Hypotension based on office and ambulatory monitoring blood pressure. Prevalence and clinical profile among a cohort of 70,997 treated hypertensives.
    J Am Soc Hypertens. 2016 Jun 27. pii: S1933-1711(16)30388.
    >> Share

  115. KATTAH A, Garovic VD
    Subclinical hypothyroidism and gestational hypertension: causal or coincidence?
    J Am Soc Hypertens. 2016 Jun 27. pii: S1933-1711(16)30384.
    >> Share

  116. TOUYZ RM
    Lower is better in hypertension, but how low should blood pressure be targeted?
    J Am Soc Hypertens. 2016 Jun 18. pii: S1933-1711(16)30380.
    >> Share

  117. ABDALLA M, Booth Iii JN, Diaz KM, Sims M, et al
    Hypertension and alterations in left ventricular structure and geometry in African Americans: the Jackson Heart Study.
    J Am Soc Hypertens. 2016 Jun 2. pii: S1933-1711(16)30324.
    >> Share

  118. BERGER A, Grossman E, Katz M, Kivity S, et al
    Exercise systolic blood pressure variability is associated with increased risk for new-onset hypertension among normotensive adults.
    J Am Soc Hypertens. 2016;10:527-535.
    >> Share

    May 2016
  119. BHATT H, Gamboa CM, Safford MM, Soliman E, et al
    Is there an association between the prevalence of atrial fibrillation and severity and control of hypertension? The REasons for Geographic And Racial Differences in Stroke study.
    J Am Soc Hypertens. 2016 May 30. pii: S1933-1711(16)30321.
    >> Share

  120. SAFAR ME
    A reappraisal of clinical research on arterial stiffness in hypertension in France.
    J Am Soc Hypertens. 2016 May 14. pii: S1933-1711(16)30243.
    >> Share

  121. TRIANTAFYLLOU A, Anyfanti P, Triantafyllou G, Zabulis X, et al
    Impaired metabolic profile is a predictor of capillary rarefaction in a population of hypertensive and normotensive individuals.
    J Am Soc Hypertens. 2016 May 13. pii: S1933-1711(16)30276.
    >> Share

  122. GERACI G, Mule G, Morreale M, Cusumano C, et al
    Association between uric acid and renal function in hypertensive patients: which role for systemic vascular involvement?
    J Am Soc Hypertens. 2016 May 12. pii: S1933-1711(16)30287.
    >> Share

  123. CUNHA RM, Arsa G, Neves EB, Lopes LC, et al
    Water aerobics is followed by short-time and immediate systolic blood pressure reduction in overweight and obese hypertensive women.
    J Am Soc Hypertens. 2016 May 12. pii: S1933-1711(16)30288.
    >> Share


  124. Retraction notice to "Urinary sodium or potassium excretion and blood pressure in adults of Shandong province, China: preliminary results of the SMASH project": [J Am Soc Hypertens 9 (2015) 754-762].
    J Am Soc Hypertens. 2016;10:472.
    >> Share

    April 2016
  125. BISOGNANO JD
    Baroreflex activation therapy: future use as therapy for severe or resistant hypertension?
    J Am Soc Hypertens. 2016 Apr 30. pii: S1933-1711(16)30284.
    >> Share

  126. WEIPERT KF, Most A, Dorr O, Helmig I, et al
    Rescue baroreflex activation therapy after Stanford B aortic dissection due to therapy-refractory hypertension.
    J Am Soc Hypertens. 2016 Apr 12. pii: S1933-1711(16)30234.
    >> Share

  127. CORREA NB, de Faria AP, Ritter AM, Sabbatini AR, et al
    A practical approach for measurement of antihypertensive medication adherence in patients with resistant hypertension.
    J Am Soc Hypertens. 2016 Apr 5. pii: S1933-1711(16)30233.
    >> Share

  128. CUADRA RH, White WB
    Severe and refractory hypertension in a young woman.
    J Am Soc Hypertens. 2016 Apr 4. pii: S1933-1711(16)30232.
    >> Share

  129. MIDDEKE M
    The pioneer in hemodynamics and pulse-wave analysis, Otto Frank.
    J Am Soc Hypertens. 2016;10:290-6.
    >> Share

  130. SAG AA, Sos TA, Benli C, Sal O, et al
    Atherosclerotic renal artery stenosis in the post-CORAL era part 2: new directions in Transcatheter Nephron Salvage following flawed revascularization trials.
    J Am Soc Hypertens. 2016;10:368-77.
    >> Share

  131. SINHA AD, Agarwal R
    Thiazides are useful agents in CKD.
    J Am Soc Hypertens. 2016;10:288-9.
    >> Share

  132. SAG AA, Inal I, Okcuoglu J, Rossignol P, et al
    Atherosclerotic renal artery stenosis in the post-CORAL era part 1: the renal penumbra concept and next-generation functional diagnostic imaging.
    J Am Soc Hypertens. 2016;10:360-7.
    >> Share

  133. SUN D, Eirin A, Ebrahimi B, Textor SC, et al
    Early atherosclerosis aggravates renal microvascular loss and fibrosis in swine renal artery stenosis.
    J Am Soc Hypertens. 2016;10:325-35.
    >> Share

    March 2016
  134. BHATT H, Siddiqui M, Judd E, Oparil S, et al
    Prevalence of pseudoresistant hypertension due to inaccurate blood pressure measurement.
    J Am Soc Hypertens. 2016 Mar 30. pii: S1933-1711(16)30225.
    >> Share

  135. AUGUST P
    Hypertensive encephalopathy: what's in a name?
    J Am Soc Hypertens. 2016 Mar 26. pii: S1933-1711(16)30228.
    >> Share

  136. MATERSON BJ, Garcia-Estrada M, Preston RA
    Hypertension in the frail elderly.
    J Am Soc Hypertens. 2016 Mar 26. pii: S1933-1711(16)30226.
    >> Share

  137. BISOGNANO JD
    Remarks from the new President of the American Society of Hypertension.
    J Am Soc Hypertens. 2016 Mar 24. pii: S1933-1711(16)30213.
    >> Share

  138. IZZO JL JR, Tobe SW
    Renal denervation for human hypertension: is there a future?
    J Am Soc Hypertens. 2016 Mar 8. pii: S1933-1711(16)30002.
    >> Share

  139. GRASSI G, Ram VS
    Evidence for a critical role of the sympathetic nervous system in hypertension.
    J Am Soc Hypertens. 2016 Mar 4. pii: S1933-1711(16)30001.
    >> Share

  140. BLOCH MJ
    Blood pressure effects of SGLT2 inhibitors make them an attractive option in diabetic patients with hypertension.
    J Am Soc Hypertens. 2016;10:186-7.
    >> Share

  141. KAPLAN NM
    ARAs to the RESCUE.
    J Am Soc Hypertens. 2016;10:187-8.
    >> Share

  142. KAPLAN NM
    Predicting home-clinic blood pressure differences.
    J Am Soc Hypertens. 2016;10:186.
    >> Share

  143. CONTRERAS DJ, Vogel EE, Saravia G, Stockins B, et al
    Derivation of a measure of systolic blood pressure mutability: a novel information theory-based metric from ambulatory blood pressure tests.
    J Am Soc Hypertens. 2016;10:217-223.
    >> Share

  144. LEVY D
    From the Editor.
    J Am Soc Hypertens. 2016;10:185.
    >> Share

  145. KIMURA G
    Importance of inhibiting sodium-glucose cotransporter and its compelling indication in type 2 diabetes: pathophysiological hypothesis.
    J Am Soc Hypertens. 2016;10:271-8.
    >> Share

  146. YOSHIDA T, Kuwabara M, Hoshide S, Kario K, et al
    Recurrence of stroke caused by nocturnal hypoxia-induced blood pressure surge in a young adult male with severe obstructive sleep apnea syndrome.
    J Am Soc Hypertens. 2016;10:201-4.
    >> Share

  147. KARAVAEV AS, Ishbulatov YM, Ponomarenko VI, Prokhorov MD, et al
    Model of human cardiovascular system with a loop of autonomic regulation of the mean arterial pressure.
    J Am Soc Hypertens. 2016;10:235-43.
    >> Share

  148. GRIM CE, Grim CM
    Auscultatory BP: still the gold standard.
    J Am Soc Hypertens. 2016;10:191-3.
    >> Share

  149. MYERS MG
    Automated office blood pressure--the preferred method for recording blood pressure.
    J Am Soc Hypertens. 2016;10:194-6.
    >> Share

  150. SHIMBO D, Abdalla M, Falzon L, Townsend RR, et al
    Studies comparing ambulatory blood pressure and home blood pressure on cardiovascular disease and mortality outcomes: a systematic review.
    J Am Soc Hypertens. 2016;10:224-234.
    >> Share

  151. IGREJA B, Wright LC, Soares-da-Silva P
    Sustained high blood pressure reduction with etamicastat, a peripheral selective dopamine beta-hydroxylase inhibitor.
    J Am Soc Hypertens. 2016;10:207-16.
    >> Share

  152. FALKNER B
    Cardiometabolic risks related to obesity severity in children and adolescents: a commentary.
    J Am Soc Hypertens. 2016;10:205-6.
    >> Share

    February 2016
  153. ELLIOTT WJ, Jurca S
    Loop diuretics are most appropriate for hypertension treatment in chronic kidney disease.
    J Am Soc Hypertens. 2016 Feb 26. pii: S1933-1711(16)00089.
    >> Share

  154. IZZO JL JR, Tobe SW
    Is there a preferred diuretic class for patients with renal impairment and hypertension?
    J Am Soc Hypertens. 2016 Feb 23. pii: S1933-1711(16)00090.
    >> Share

  155. BUDOFF MJ
    American Society of Hypertension position article: central blood pressure waveforms in health and disease.
    J Am Soc Hypertens. 2016 Feb 23. pii: S1933-1711(16)00086.
    >> Share

  156. MARUF FA, Akinpelu AO, Salako BL, Akinyemi JO, et al
    Effects of aerobic dance training on blood pressure in individuals with uncontrolled hypertension on two antihypertensive drugs: a randomized clinical trial.
    J Am Soc Hypertens. 2016 Feb 12. pii: S1933-1711(16)00050.
    >> Share

  157. TADIC M, Cuspidi C, Vukomanovic V, Celic V, et al
    The influence of masked hypertension on the right ventricle: is everything really masked?
    J Am Soc Hypertens. 2016 Feb 11. pii: S1933-1711(16)00049.
    >> Share

  158. NEGRONI-BALASQUIDE X, Bell CS, Samuel J, Samuels JA, et al
    Is one measurement enough to evaluate blood pressure among adolescents? A blood pressure screening experience in more than 9000 children with a subset comparison of auscultatory to mercury measurements.
    J Am Soc Hypertens. 2016;10:95-100.
    >> Share

  159. RITCHIE J, Green D, Alderson HV, Chrysochou C, et al
    Associations of antiplatelet therapy and beta blockade with patient outcomes in atherosclerotic renovascular disease.
    J Am Soc Hypertens. 2016;10:149-158.
    >> Share

  160. BYRD JB, Morishita M, Bard RL, Das R, et al
    Acute increase in blood pressure during inhalation of coarse particulate matter air pollution from an urban location.
    J Am Soc Hypertens. 2016;10:133-139.
    >> Share

  161. LIN IC, Hsu CN, Lo MH, Chien SJ, et al
    Low urinary citrulline/arginine ratio associated with blood pressure abnormalities and arterial stiffness in childhood chronic kidney disease.
    J Am Soc Hypertens. 2016;10:115-23.
    >> Share

    January 2016
  162. COVASSIN N, Somers VK
    Sleep apnea, hypertension, and hemorrhagic stroke-deja vu all over again.
    J Am Soc Hypertens. 2016 Jan 30. pii: S1933-1711(16)00043.
    >> Share

  163. STEC DE, Juncos LA, Granger JP
    Renal intramedullary infusion of tempol normalizes the blood pressure response to intrarenal blockade of heme oxygenase-1 in angiotensin II-dependent hypertension.
    J Am Soc Hypertens. 2016 Jan 30. pii: S1933-1711(16)00048.
    >> Share

  164. CHRISTOPOULOU F, Rizos EC, Kosta P, Argyropoulou MI, et al
    Does this patient have hypertensive encephalopathy?
    J Am Soc Hypertens. 2016 Jan 29. pii: S1933-1711(16)00045.
    >> Share

  165. SMITH SM, Carris NW, Dietrich E, Gums JG, et al
    Physician-pharmacist collaboration versus usual care for treatment-resistant hypertension.
    J Am Soc Hypertens. 2016 Jan 18. pii: S1933-1711(16)00035.
    >> Share

  166. TOBE SW, Izzo JL Jr
    Controversies in hypertension: how should BP be measured in the office?
    J Am Soc Hypertens. 2016 Jan 11. pii: S1933-1711(16)00006.
    >> Share

  167. SERAVALLE G, Brambilla G, Pizzalla DP, Casati A, et al
    Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension.
    J Am Soc Hypertens. 2016 Jan 11. pii: S1933-1711(16)00007.
    >> Share

  168. FANG J, Moore L, Loustalot F, Yang Q, et al
    Reporting of adherence to healthy lifestyle behaviors among hypertensive adults in the 50 states and the District of Columbia, 2013.
    J Am Soc Hypertens. 2016 Jan 11. pii: S1933-1711(16)00009.
    >> Share

  169. IZZO JL JR, Tobe SW
    Should age determine hypertension management? Recommendations from current guidelines.
    J Am Soc Hypertens. 2016 Jan 6. pii: S1933-1711(16)00003.
    >> Share

  170. GAUDRON PD, Liu D, Scholz F, Hu K, et al
    The septal bulge-an early echocardiographic sign in hypertensive heart disease.
    J Am Soc Hypertens. 2016;10:70-80.
    >> Share

  171. IZZO JL JR
    Age should not be a primary consideration in the management of hypertension.
    J Am Soc Hypertens. 2016;10:12-5.
    >> Share

  172. TOBE SW
    Age matters in the treatment and management of hypertension.
    J Am Soc Hypertens. 2016;10:10-1.
    >> Share

  173. IZZO J, Tobe S, Levy D
    Controversies in hypertension: rationale and approach.
    J Am Soc Hypertens. 2016;10:6.
    >> Share

  174. KAPLAN NM
    Poor Choices of Antihypertensive Drugs.
    J Am Soc Hypertens. 2016;10:3-4.
    >> Share

  175. BLOCH MJ
    Spironolactone is the Most Effective "add-on" Medication For Resistant Hypertension.
    J Am Soc Hypertens. 2016;10:3.
    >> Share

  176. KAPLAN NM
    Home Monitoring in the US: Its About Time.
    J Am Soc Hypertens. 2016;10:4-5.
    >> Share

  177. DOGAN H, Harman E, Kocoglu H, Sargin G, et al
    Can metabolic control variables of diabetic patients predict their quality of life?
    J Am Soc Hypertens. 2016;10:81-8.
    >> Share

  178. LEVY D
    From the Editor.
    J Am Soc Hypertens. 2016;10:1-2.
    >> Share

  179. IHSAN M, Nunez A, Liu Y, Ahmed F, et al
    Assessment of arterial stiffness from pedal artery Korotkoff sound recordings: feasibility and potential utility.
    J Am Soc Hypertens. 2016;10:34-40.
    >> Share

    December 2015
  180. ATES I, Ozkayar N, Inan B, Yilmaz FM, et al
    Dynamic thiol/disulphide homeostasis in patients with newly diagnosed primary hypertension.
    J Am Soc Hypertens. 2015 Dec 15. pii: S1933-1711(15)00810.
    >> Share

  181. MATHEW RO, Nayer A, Asif A
    The endothelium as the common denominator in malignant hypertension and thrombotic microangiopathy.
    J Am Soc Hypertens. 2015 Dec 15. pii: S1933-1711(15)00809.
    >> Share

  182. THOMAS IC, Ratigan AR, Rifkin DE, Ix JH, et al
    The association of renal artery calcification with hypertension in community-living individuals: the multiethnic study of atherosclerosis.
    J Am Soc Hypertens. 2015 Dec 13. pii: S1933-1711(15)00805.
    >> Share

  183. YANG F, Qian D, Hu D
    Prevalence, awareness, treatment, and control of hypertension in the older population: results from the multiple national studies on ageing.
    J Am Soc Hypertens. 2015 Dec 8. pii: S1933-1711(15)00800.
    >> Share

  184. FAZAKAS A, Szelenyi Z, Szenasi G, Nyiro G, et al
    Genetic predisposition in patients with hypertension and normal ejection fraction to oxidative stress.
    J Am Soc Hypertens. 2015 Dec 2. pii: S1933-1711(15)00797.
    >> Share

  185. FORTUNA RJ, Nagel AK, Rose E, McCann R, et al
    Effectiveness of a multidisciplinary intervention to improve hypertension control in an urban underserved practice.
    J Am Soc Hypertens. 2015;9:966-74.
    >> Share

  186. YERASI C, Baker NC, Jonnalagadda AK, Torguson R, et al
    Assessment of hypertension control and clinical course of patients excluded from the SYMPLICITY HTN-3 trial.
    J Am Soc Hypertens. 2015;9:959-65.
    >> Share

  187. AKIOYAMEN L, Levine M, Sherifali D, O'Reilly D, et al
    Cardiovascular and cerebrovascular outcomes of long-term angiotensin receptor blockade: meta-analyses of trials in essential hypertension.
    J Am Soc Hypertens. 2015 Dec 1. pii: S1933-1711(15)00787.
    >> Share

    November 2015
  188. SMULYAN H, Mookherjee S, Safar ME
    The two faces of hypertension: role of aortic stiffness.
    J Am Soc Hypertens. 2015 Nov 26. pii: S1933-1711(15)00796.
    >> Share

  189. HARTZELL K, Avis K, Lozano D, Feig D, et al
    Obstructive sleep apnea and periodic limb movement disorder in a population of children with hypertension and/or nocturnal nondipping blood pressures.
    J Am Soc Hypertens. 2015 Nov 22. pii: S1933-1711(15)00794.
    >> Share

  190. RAMASWAMY P, Chikkabyrappa S, Donda K, Osmolovsky M, et al
    Relationship of ambulatory blood pressure and body mass index to left ventricular mass index in pediatric patients with casual hypertension.
    J Am Soc Hypertens. 2015 Nov 22. pii: S1933-1711(15)00793.
    >> Share

  191. BLOCH MJ, Basile JN
    Ambulatory blood pressure monitoring to diagnose hypertension-an idea whose time has come.
    J Am Soc Hypertens. 2015 Nov 9. pii: S1933-1711(15)00749.
    >> Share

  192. TOWNSEND RR, Rosendorff C, Nichols WW, Edwards DG, et al
    American Society of Hypertension position paper: central blood pressure waveforms in health and disease.
    J Am Soc Hypertens. 2015 Nov 5. pii: S1933-1711(15)00751.
    >> Share

    October 2015
  193. MUGOMERI E, Ramathebane MV, Maja L, Chatanga P, et al
    Knowledge of disease condition and medications among hypertension patients in Lesotho.
    J Am Soc Hypertens. 2015 Oct 31. pii: S1933-1711(15)00748.
    >> Share

  194. KUZNETSOVA T, Haddad F, Knez J, Rosenberg-Hasson Y, et al
    Cytokines profile in hypertensive patients with left ventricular remodeling and dysfunction.
    J Am Soc Hypertens. 2015 Oct 17. pii: S1933-1711(15)00740.
    >> Share

  195. LEVY D
    From the Editor.
    J Am Soc Hypertens. 2015;9:745-6.
    >> Share

    September 2015
  196. STERNBERG CA, Materson BJ, Nayer A
    Vitamin D for hypertension: should we continue the search?
    J Am Soc Hypertens. 2015 Sep 25. pii: S1933-1711(15)00707.
    >> Share

    August 2015
  197. ZIMLICHMAN R
    The reply.
    J Am Soc Hypertens. 2015;9:658.
    >> Share

    May 2015
  198. GORELICK PB
    Should blood pressure be lowered in acute ischemic stroke? The CATIS trial.
    J Am Soc Hypertens. 2015;9:331-3.
    >> Share

  199. LEVY D
    From the editor.
    J Am Soc Hypertens. 2015;9:329-30.
    >> Share

  200. APARICIO LS, Alfie J, Barochiner J, Cuffaro PE, et al
    Comparison of atenolol versus bisoprolol with noninvasive hemodynamic and pulse wave assessment.
    J Am Soc Hypertens. 2015;9:390-6.
    >> Share

    April 2015
  201. MCMULLAN CJ, Yano Y, Bakris GL, Kario K, et al
    Racial impact of diurnal variations in blood pressure on cardiovascular events in chronic kidney disease.
    J Am Soc Hypertens. 2015;9:299-306.
    >> Share

  202. GORELICK PB
    Treatment: special conditions: co-existing vascular disease: stroke.
    J Am Soc Hypertens. 2015;9:320-5.
    >> Share

    March 2015
  203. MCGREEVY C, Barry M, Davenport C, Byrne B, et al
    The effect of vitamin D supplementation on arterial stiffness in an elderly community-based population.
    J Am Soc Hypertens. 2015;9:176-83.
    >> Share

  204. HAYEK SS, Poole JC, Neuman R, Morris AA, et al
    Differential effects of nebivolol and metoprolol on arterial stiffness, circulating progenitor cells, and oxidative stress.
    J Am Soc Hypertens. 2015;9:206-13.
    >> Share

  205. PINJUH MARKOTA N, Rumboldt M, Rumboldt Z
    Emphasized warning reduces salt intake: a randomized controlled trial.
    J Am Soc Hypertens. 2015;9:214-20.
    >> Share

    February 2015
  206. WHELTON PK
    Treatment: special conditions. Prevention/public health strategies.
    J Am Soc Hypertens. 2015;9:161-3.
    >> Share

  207. EPSTEIN M, de Marchena E
    Is the failure of SYMPLICITY HTN-3 trial to meet its efficacy endpoint the "end of the road" for renal denervation?
    J Am Soc Hypertens. 2015;9:140-9.
    >> Share

    January 2015
  208. BATISKY DL
    Treatment: special conditions: assessing blood pressure in children and adolescents.
    J Am Soc Hypertens. 2015;9:64-5.
    >> Share

  209. MALIHA G, Townsend RR
    SGLT2 inhibitors: their potential reduction in blood pressure.
    J Am Soc Hypertens. 2015;9:48-53.
    >> Share

  210. LOHR JW, Golzy M, Carter RL, Arora P, et al
    Elevated systolic blood pressure is associated with increased incidence of chronic kidney disease but not mortality in elderly veterans.
    J Am Soc Hypertens. 2015;9:29-37.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016